GTF2I and thymus neoplasm: The overexpression of YAP in lower-grade tumors reconciles with the findings derived from an integrated molecular analysis of a large TET cohort, which unveiled YAP as one of the upregulated genes in tumors harboring GTF2I mutations that represent the hallmark genetic driver of low-grade thymic tumors [33].